Aclaris Therapeutics
ACRS
#6746
Rank
ยฃ0.56 B
Marketcap
ยฃ4.04
Share price
-1.92%
Change (1 day)
224.58%
Change (1 year)

Revenue for Aclaris Therapeutics (ACRS)

Revenue in 2026 (TTM): ยฃ6.21 Million

According to Aclaris Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ6.28 Million. In 2025 the company made a revenue of ยฃ5.81 Million a decrease over the revenue in the year 2024 that were of ยฃ14.91 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aclaris Therapeutics from 2015 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ6.21 M6.98%
2025 ยฃ5.81 M-61.05%
2024 ยฃ14.91 M-39.18%
2023 ยฃ24.52 M-0.26%
2022 ยฃ24.59 M390.99%
2021 ยฃ5 M5.33%
2020 ยฃ4.75 M47.52%
2019 ยฃ3.22 M-57.29%
2018 ยฃ7.54 M506.12%
2017 ยฃ1.24 M
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA